238 related articles for article (PubMed ID: 32883810)
1. Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells.
Allen A; Gau D; Francoeur P; Sturm J; Wang Y; Martin R; Maranchie J; Duensing A; Kaczorowski A; Duensing S; Wu L; Lotze MT; Koes D; Storkus WJ; Roy P
J Biol Chem; 2020 Nov; 295(46):15636-15649. PubMed ID: 32883810
[TBL] [Abstract][Full Text] [Related]
2. Structure-based virtual screening identifies a small-molecule inhibitor of the profilin 1-actin interaction.
Gau D; Lewis T; McDermott L; Wipf P; Koes D; Roy P
J Biol Chem; 2018 Feb; 293(7):2606-2616. PubMed ID: 29282288
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial profilin-1 drives a protumorigenic tumor microenvironment and tumor progression in renal cancer.
Gau D; Daoud A; Allen A; Joy M; Sagan A; Lee S; Lucas PC; Duensing S; Boone D; Osmanbeyoglu HU; Roy P
J Biol Chem; 2023 Aug; 299(8):105044. PubMed ID: 37451478
[TBL] [Abstract][Full Text] [Related]
4. Profilin-1 expression is associated with high grade and stage and decreased disease-free survival in renal cell carcinoma.
Karamchandani JR; Gabril MY; Ibrahim R; Scorilas A; Filter E; Finelli A; Lee JY; Ordon M; Pasic M; Romaschin AD; Yousef GM
Hum Pathol; 2015 May; 46(5):673-80. PubMed ID: 25704627
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
6. Disruption of profilin1 function suppresses developmental and pathological retinal neovascularization.
Gau D; Vignaud L; Allen A; Guo Z; Sahel J; Boone D; Koes D; Guillonneau X; Roy P
J Biol Chem; 2020 Jul; 295(28):9618-9629. PubMed ID: 32444495
[TBL] [Abstract][Full Text] [Related]
7. The VASP-profilin1 (Pfn1) interaction is critical for efficient cell migration and is regulated by cell-substrate adhesion in a PKA-dependent manner.
Gau D; Veon W; Shroff SG; Roy P
J Biol Chem; 2019 Apr; 294(17):6972-6985. PubMed ID: 30814249
[TBL] [Abstract][Full Text] [Related]
8. A balanced level of profilin-1 promotes stemness and tumor-initiating potential of breast cancer cells.
Jiang C; Ding Z; Joy M; Chakraborty S; Kim SH; Bottcher R; Condeelis J; Singh S; Roy P
Cell Cycle; 2017; 16(24):2366-2373. PubMed ID: 28699810
[TBL] [Abstract][Full Text] [Related]
9. Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer models.
Frantzi M; Klimou Z; Makridakis M; Zoidakis J; Latosinska A; Borràs DM; Janssen B; Giannopoulou I; Lygirou V; Lazaris AC; Anagnou NP; Mischak H; Roubelakis MG; Vlahou A
Oncotarget; 2016 Oct; 7(43):70750-70768. PubMed ID: 27683119
[TBL] [Abstract][Full Text] [Related]
10. Loss of profilin-1 expression enhances breast cancer cell motility by Ena/VASP proteins.
Bae YH; Ding Z; Zou L; Wells A; Gertler F; Roy P
J Cell Physiol; 2009 May; 219(2):354-64. PubMed ID: 19115233
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression.
Wang C; Cai L; Liu J; Wang G; Li H; Wang X; Xu W; Ren M; Feng L; Liu P; Zhang C
Cell Physiol Biochem; 2017; 43(6):2405-2419. PubMed ID: 29073630
[TBL] [Abstract][Full Text] [Related]
12. Profilin-1 downregulation has contrasting effects on early vs late steps of breast cancer metastasis.
Ding Z; Joy M; Bhargava R; Gunsaulus M; Lakshman N; Miron-Mendoza M; Petroll M; Condeelis J; Wells A; Roy P
Oncogene; 2014 Apr; 33(16):2065-74. PubMed ID: 23686314
[TBL] [Abstract][Full Text] [Related]
13. Alterative Expression and Localization of Profilin 1/VASPpS157 and Cofilin 1/VASPpS239 Regulates Metastatic Growth and Is Modified by DHA Supplementation.
Ali M; Heyob K; Jacob NK; Rogers LK
Mol Cancer Ther; 2016 Sep; 15(9):2220-31. PubMed ID: 27496138
[TBL] [Abstract][Full Text] [Related]
14. CCL5-dependent mast cell infiltration into the tumor microenvironment in clear cell renal cell carcinoma patients.
Liu T; Xia Q; Zhang H; Wang Z; Yang W; Gu X; Hou T; Chen Y; Pei X; Zhu G; He D; Li L; Xu S
Aging (Albany NY); 2020 Nov; 12(21):21809-21836. PubMed ID: 33177244
[TBL] [Abstract][Full Text] [Related]
15. Profilin-1 is a negative regulator of mammary carcinoma aggressiveness.
Zou L; Jaramillo M; Whaley D; Wells A; Panchapakesa V; Das T; Roy P
Br J Cancer; 2007 Nov; 97(10):1361-71. PubMed ID: 17940506
[TBL] [Abstract][Full Text] [Related]
16. Identification of a new aggressive axis driven by ciliogenesis and absence of VDAC1-ΔC in clear cell Renal Cell Carcinoma patients.
Fabbri L; Dufies M; Lacas-Gervais S; Gardie B; Gad-Lapiteau S; Parola J; Nottet N; Meyenberg Cunha de Padua M; Contenti J; Borchiellini D; Ferrero JM; Leclercq NR; Ambrosetti D; Mograbi B; Richard S; Viotti J; Chamorey E; Sadaghianloo N; Rouleau M; Craigen WJ; Mari B; Clavel S; Pagès G; Pouysségur J; Bost F; Mazure NM
Theranostics; 2020; 10(6):2696-2713. PubMed ID: 32194829
[No Abstract] [Full Text] [Related]
17. VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling.
Sun J; Tang Q; Gao Y; Zhang W; Zhao Z; Yang F; Hu X; Zhang D; Wang Y; Zhang H; Song B; Zhang B; Wang H
J Exp Clin Cancer Res; 2020 Jun; 39(1):104. PubMed ID: 32513235
[TBL] [Abstract][Full Text] [Related]
18. Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in Von Hippel-Lindau patients.
Cascón A; Escobar B; Montero-Conde C; Rodríguez-Antona C; Ruiz-Llorente S; Osorio A; Mercadillo F; Letón R; Campos JM; García-Sagredo JM; Benítez J; Malumbres M; Robledo M
Hum Mutat; 2007 Jun; 28(6):613-21. PubMed ID: 17311301
[TBL] [Abstract][Full Text] [Related]
19. TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma.
Pan Q; Cheng G; Liu Y; Xu T; Zhang H; Li B
Int J Oncol; 2020 May; 56(5):1101-1114. PubMed ID: 32319572
[TBL] [Abstract][Full Text] [Related]
20. The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.
Niu X; Zhang T; Liao L; Zhou L; Lindner DJ; Zhou M; Rini B; Yan Q; Yang H
Oncogene; 2012 Feb; 31(6):776-86. PubMed ID: 21725364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]